Nu-Med Plus (NUMD) Shares Outstanding (Weighted Average) (2011 - 2025)

Nu-Med Plus has disclosed Shares Outstanding (Weighted Average) across 15 years of filings, most recently posting $83.5 million for Q4 2025.

• Shares Outstanding (Weighted Average) for Q4 2025 came in at $83.5 million, changed 0.0% year-over-year; the trailing twelve-month figure through Dec 2025 was $83.5 million (changed 0.0% YoY), and the FY2025 annual result was $83.5 million, changed 0.0% from the prior year.
• Shares Outstanding (Weighted Average) came in at $83.5 million for Q4 2025 at Nu-Med Plus, roughly flat from $83.5 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $83.5 million in Q1 2024 to a low of $73.4 million in Q4 2021.
• The 5-year median for Shares Outstanding (Weighted Average) is $81.3 million (2023), against an average of $81.2 million.
• Across the five-year window, Shares Outstanding (Weighted Average) jumped 70.29% in 2021 and changed 0.0% in 2022, its largest moves.
• Nu-Med Plus' Shares Outstanding (Weighted Average) stood at $73.4 million in 2021, then advanced by 8.96% to $80.0 million in 2022, then grew by 2.15% to $81.7 million in 2023, then rose by 2.3% to $83.5 million in 2024, then changed by 0.0% to $83.5 million in 2025.
• The last three Shares Outstanding (Weighted Average) figures came in at $83.5 million (Q4 2025), $83.5 million (Q3 2025), and $83.5 million (Q2 2025), per Business Quant data.